Drug Profile
Research programme: interferon-gamma variants - Nautilus Biotech
Alternative Names: IFN-gamma variants - Nautilus BiotechLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Nautilus Biotech
- Class Interferons
- Mechanism of Action Interferon gamma stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chronic granulomatous disease; Osteopetrosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Chronic-granulomatous-disease in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteopetrosis in France
- 01 Jun 2005 Preclinical trials in Chronic granulomatous disease in France (unspecified route)